Title |
(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls |
|---|---|
Involved |
Solveig Tiepolt (Verfasser)
Georg-Alexander Becker (Verfasser) Stephan Wilke (Verfasser) Diego Cecchin (Verfasser)
Michael Rullmann (Verfasser)
Philipp M. Meyer (Verfasser) Henryk Barthel (Verfasser) Swen Hesse (Verfasser) Marianne Patt (Verfasser) Julia Luthardt (Verfasser) Gudrun Wagenknecht (Verfasser) Bernhard Sattler (Verfasser) Winnie Deuther-Conrad (Verfasser) Friedrich-Alexander Ludwig (Verfasser) Steffen Fischer (Verfasser) Hermann-Josef Gertz (Verfasser) René Smits (Verfasser) Alexander Hoepping (Verfasser) Jörg Steinbach (Verfasser) Peter Brust (Verfasser) Osama Sabri (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
European journal of nuclear medicine and molecular imaging : official journal of the European Association of Nuclear Medicine (EANM) 16.9.2020, Seite 1-16 |
Published |
2020 |
Language |
|
Country |
|
Topic |
|
Subject |
Nuclear Medicine. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2020110518030324975827 (URN) |
Record ID |
1220884901 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: